Chronic Obstructive Pulmonary Disease in Latin America

The PLATINO and PREPOCOL population-based studies documented the prevalence of chronic obstructive pulmonary disease (COPD) in several Latin American (Mexico City, Sao Paulo, Montevideo, Santiago and Caracas) and Colombian (Medellin, Bogota, Barranquilla, Bucaramanga and Cali) cities. COPD ranged be...

Full description

Bibliographic Details
Main Authors: Rogelio Perez-Padilla, Ana Maria B. Menezes
Format: Article
Language:English
Published: Levy Library Press 2019-01-01
Series:Annals of Global Health
Online Access:https://annalsofglobalhealth.org/articles/2418
id doaj-9748a86f3586488ab648f5a3fba4af9f
record_format Article
spelling doaj-9748a86f3586488ab648f5a3fba4af9f2020-11-24T23:07:02ZengLevy Library PressAnnals of Global Health2214-99962019-01-0185110.5334/aogh.24182269Chronic Obstructive Pulmonary Disease in Latin AmericaRogelio Perez-Padilla0Ana Maria B. Menezes1Instituto Nacional de Enfermedades Respiratorias, Ciudad de MéxicoFederal University of PelotasThe PLATINO and PREPOCOL population-based studies documented the prevalence of chronic obstructive pulmonary disease (COPD) in several Latin American (Mexico City, Sao Paulo, Montevideo, Santiago and Caracas) and Colombian (Medellin, Bogota, Barranquilla, Bucaramanga and Cali) cities. COPD ranged between 6.2 and 19.6% in individuals ≥40 years of age, with substantial rates of underdiagnosis (up to 89%) but also overdiagnosis, mostly due to the lack of spirometric confirmation. The main risk factor was tobacco smoking, but male gender and age were also associated with COPD. COPD in never smokers represented about one third of the cases and was associated with previous history of tuberculosis or a diagnosis of asthma. COPD associated with biomass smoke exposure was a common clinical phenotype in Latin America, found as a risk factor in PREPOCOL and other observational studies in the region. Smoking has been decreasing in Latin America and efforts have been made to implement cleaner biomass stoves. Unfortunately, treatment of COPD in Latin America remains highly variable with low rates of smoking cessation counselling, low use of inhaled bronchodilators and influenza vaccination. A primary-care approach to COPD, particularly in the form of integrated programs is lacking but would be critical to improving rates of diagnosis and treatment of COPD.https://annalsofglobalhealth.org/articles/2418
collection DOAJ
language English
format Article
sources DOAJ
author Rogelio Perez-Padilla
Ana Maria B. Menezes
spellingShingle Rogelio Perez-Padilla
Ana Maria B. Menezes
Chronic Obstructive Pulmonary Disease in Latin America
Annals of Global Health
author_facet Rogelio Perez-Padilla
Ana Maria B. Menezes
author_sort Rogelio Perez-Padilla
title Chronic Obstructive Pulmonary Disease in Latin America
title_short Chronic Obstructive Pulmonary Disease in Latin America
title_full Chronic Obstructive Pulmonary Disease in Latin America
title_fullStr Chronic Obstructive Pulmonary Disease in Latin America
title_full_unstemmed Chronic Obstructive Pulmonary Disease in Latin America
title_sort chronic obstructive pulmonary disease in latin america
publisher Levy Library Press
series Annals of Global Health
issn 2214-9996
publishDate 2019-01-01
description The PLATINO and PREPOCOL population-based studies documented the prevalence of chronic obstructive pulmonary disease (COPD) in several Latin American (Mexico City, Sao Paulo, Montevideo, Santiago and Caracas) and Colombian (Medellin, Bogota, Barranquilla, Bucaramanga and Cali) cities. COPD ranged between 6.2 and 19.6% in individuals ≥40 years of age, with substantial rates of underdiagnosis (up to 89%) but also overdiagnosis, mostly due to the lack of spirometric confirmation. The main risk factor was tobacco smoking, but male gender and age were also associated with COPD. COPD in never smokers represented about one third of the cases and was associated with previous history of tuberculosis or a diagnosis of asthma. COPD associated with biomass smoke exposure was a common clinical phenotype in Latin America, found as a risk factor in PREPOCOL and other observational studies in the region. Smoking has been decreasing in Latin America and efforts have been made to implement cleaner biomass stoves. Unfortunately, treatment of COPD in Latin America remains highly variable with low rates of smoking cessation counselling, low use of inhaled bronchodilators and influenza vaccination. A primary-care approach to COPD, particularly in the form of integrated programs is lacking but would be critical to improving rates of diagnosis and treatment of COPD.
url https://annalsofglobalhealth.org/articles/2418
work_keys_str_mv AT rogelioperezpadilla chronicobstructivepulmonarydiseaseinlatinamerica
AT anamariabmenezes chronicobstructivepulmonarydiseaseinlatinamerica
_version_ 1725620544443777024